These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20827909)

  • 21. Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
    Noecker RS; Dirks MS; Choplin N;
    Am J Ophthalmol; 2004 Jan; 137(1):210-1; author reply 211-2. PubMed ID: 14700685
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trials.
    Aptel F; Cucherat M; Denis P
    Eur J Ophthalmol; 2012; 22(1):5-18. PubMed ID: 22167538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness.
    Zhong Y; Shen X; Yu J; Tan H; Cheng Y
    Cornea; 2011 Aug; 30(8):861-4. PubMed ID: 21499083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
    Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refill rates and budget impact of glaucoma lipid therapy: a retrospective database analysis.
    Walt JG; Wilensky JT; Fiscella R; Chiang TH; Guckian A
    Clin Drug Investig; 2007; 27(12):819-25. PubMed ID: 18020539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials.
    Honrubia F; García-Sánchez J; Polo V; de la Casa JM; Soto J
    Br J Ophthalmol; 2009 Mar; 93(3):316-21. PubMed ID: 19019922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy.
    Paranhos A; Mendonça M; Silva MJ; Giampani J; Torres RJ; Della Paolera M; Russ H; Lottenberg CL
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):611-5. PubMed ID: 21029020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective.
    Hommer A; Wickstrøm J; Friis MM; Steeds C; Thygesen J; Ferreras A; Gouws P; Buchholz P
    Curr Med Res Opin; 2008 Apr; 24(4):1057-63. PubMed ID: 18315942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
    Kymes S
    Am J Ophthalmol; 2006 Aug; 142(2):354; author reply 354-5. PubMed ID: 16876536
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter study.
    Bernstein P
    Am J Ophthalmol; 2004 Feb; 137(2):387-8; author reply 388-9. PubMed ID: 14962451
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparison of intraocular pressure lowering efficacy of bimatoprost / timolol fixed combination and other glaucoma medications in the treatment of glaucoma].
    Skorkovská K
    Cesk Slov Oftalmol; 2008 Jul; 64(4):144-8. PubMed ID: 18780653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
    Li N; Chen XM; Zhou Y; Wei ML; Yao X
    Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost.
    Stewart WC; Kolker AE; Stewart JA; Leech J; Jackson AL
    Am J Ophthalmol; 2003 Mar; 135(3):314-20. PubMed ID: 12614748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.
    Arcieri ES; Santana A; Rocha FN; Guapo GL; Costa VP
    Arch Ophthalmol; 2005 Feb; 123(2):186-92. PubMed ID: 15710814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
    Cantor LB; WuDunn D; Cortes A; Hoop J; Knotts S
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S12-8. PubMed ID: 15016557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery.
    Arici MK; Erdogan H; Toker I; Vural A; Topalkara A
    J Ocul Pharmacol Ther; 2006 Feb; 22(1):34-40. PubMed ID: 16503773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.
    Parmaksiz S; Yüksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y
    Eur J Ophthalmol; 2006; 16(1):73-80. PubMed ID: 16496249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost.
    Sonty S; Donthamsetti V; Vangipuram G; Ahmad A
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):517-20. PubMed ID: 18800869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.